Procter & Gamble Health Ltd PGHL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹5,251.05
- Day Range
- ₹5,221.05–5,566.00
- 52-Week Range
- ₹4,636.55–5,642.85
- Bid/Ask
- ₹5,499.95 / ₹5,527.35
- Market Cap
- ₹91.75 Bil
- Volume/Avg
- 30,041 / 9,365
Key Statistics
- Price/Earnings (Normalized)
- 39.58
- Price/Sales
- 7.57
- Dividend Yield (Trailing)
- 1.81%
- Dividend Yield (Forward)
- 2.17%
- Total Yield
- 1.90%
Company Profile
Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 1,407
- Website
- https://www.pghealthindia.com
Comparables
Valuation
|
Metric
|
PGHL
|
530199
|
500488
|
|---|---|---|---|
Price/Earnings (Normalized) | 39.58 | 53.34 | 49.77 |
Price/Book Value | 16.19 | 7.06 | 16.95 |
Price/Sales | 7.57 | 6.62 | 10.47 |
Price/Cash Flow | 36.26 | 75.46 | 57.26 |
Price/Earnings
PGHL
530199
500488
Financial Strength
|
Metric
|
PGHL
|
530199
|
500488
|
|---|---|---|---|
Quick Ratio | 1.57 | 1.22 | 1.91 |
Current Ratio | 2.39 | 1.90 | 2.42 |
Interest Coverage | 380.61 | 9.20 | 122.46 |
Quick Ratio
PGHL
530199
500488
Profitability
|
Metric
|
PGHL
|
530199
|
500488
|
|---|---|---|---|
Return on Assets (Normalized) | 24.63% | — | — |
Return on Equity (Normalized) | 34.95% | — | — |
Return on Invested Capital (Normalized) | 34.49% | — | — |
Return on Assets
PGHL
530199
500488
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Rtchybjb | Bry | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Yjsklybv | Xtckhks | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Clnfgqljp | Mypt | $48.4 Bil | |||
| Viatris Inc
VTRS
| Hfthwrynp | Vmrj | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Tljsgsq | Gkgxt | $13.5 Bil | |||
| Catalent Inc
CTLT
| Tmxnldmv | Wkdjcmb | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Vqvwxhpvl | Ztlbxl | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Xrhkjhn | Fwtf | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Mbxwlvgnd | Hgv | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Pxnlnvg | Pmyc | $2.3 Bil |
United States